Advertisement
<< Back To Article
Injectable Long-Acting Cabotegravir Shows Promise As PrEP in Early Safety Trial

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

cinciskeet

Why oh why is this study just for gay men? For too long testosterone has been testing drugs that estrogen uses when the drug goes to the pipeline. I see this as a form of discrimination.

May 16, 2016 Ohio

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.